Results 51 to 60 of about 5,977 (216)
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Solitary Plexiform Neurofibroma of the Gingiva: Unique Presentation in the Oral Cavity [PDF]
Journal of Clinical and Diagnostic Research, 2013 Neurofibromas are benign tumours originating from the nerve sheath. Amongst the histological variants, plexiform types are considered exclusive. These are poorly circumscribed, locally invasive and may exhibit sarcomatous potential.
SURAMYA S. +3 more
doaj +1 more source
Voluminous plexiform neurofibromas of the neck region in neurofibromatosis 1 [PDF]
, 2014 Objetivo. Presentar las características clínicas, de imagen y evolutivas de una serie de pacientes con neurofibromatosis tipo 1 que desarrollaron durante la infancia neurofibromas plexiformes voluminosos en el cuello (NFPVC). Pacientes y métodos. Nueve
López-Barea, Fernando +5 more
core +1 more source
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1microdeletions [PDF]
, 2012 BACKGROUND: Neurofibromatosis type-1 (NF1) is caused by mutations of the NF1 gene at 17q11.2. In 95% of non-founder NF1 patients, NF1 mutations are identifiable by means of a comprehensive mutation analysis. 5-10% of these patients harbour microdeletions
David N Cooper +6 more
core +2 more sources
Pathogenic Neurofibromatosis type 1 gene variants in tumors of non‐NF1 patients and role of R1276
FEBS Open Bio, Volume 16, Issue 4, Page 803-813, April 2026.Somatic variants of the neurofibromatosis type 1 (NF1) gene occur across neoplasms without clinical manifestation of the disease NF1. We identified emerging somatic pathogenic NF1 variants and hotspots, for example, at the arginine finger 1276. Those missense variants provide fundamental information about neurofibromin's role in cancer.
Mareike Selig +7 more
wiley +1 more source
MedComm, Volume 7, Issue 4, April 2026.Illustration of the microenvironment factors driving malignant progression in MPNSTs. ABSTRACT Neurofibromatosis type 1 (NF1) is characterized by the development of benign plexiform neurofibromas (PNFs). In 10%–15% of patients, these tumors undergo malignant transformation into aggressive malignant peripheral nerve sheath tumors (MPNSTs).
Ling‐Ling Ge +11 more
wiley +1 more source
European Journal of Medical Research, 2010 Plexiform neurofibroma (PN) is a rare benign tumor and a special subtype of neurofibromatosis type 1 (NF1). Though the incidence is low, giant PN of the craniomaxillofacial region could result in severe hemifacial hypertrophy which is known as a typical ...
Feng Y, Yang Z, Chen T, Wang Q, Deng W
doaj +1 more source
Solitary intraosseous neurofibroma of the mandible. Apropos of a case [PDF]
, 2011 Neurofibroma is a benign neoplasm derived from peripheral nerves. Most of these are associated with Neurofibromatosis but may also occur as solitary lesions. When found on the head and neck they are generally located in the soft tissue.
Deichler, Javiera +5 more
core +1 more source
Plexiform Neurofibroma of Penis
Urology Journal, 2007 Hamid Mazdak, Mohammad Reza Gharaati
doaj +3 more sources
Respiratory Medicine Case Reports, 2021 A toddler with neurofibromatosis type 1 (NF1) was evaluated for tuberculosis (TB) after exposure. Chest X-ray (CXR) revealed a mediastinal mass indicating lymphadenopathy. However, magnetic resonance imaging showed a large plexiform thoracic neurofibroma.
Renate Krüger +4 more
doaj +1 more source